SCHEMBL5164072

SCHEMBL5164072

NC(=O)c1cccc(CCC(=O)Nc2ccc(N3CCCCC3=O)cc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.51
RAB9A P51151 5/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
ALDH1A1 P00352 2/20 0.51
TP53 P04637 1/20 0.51
GLA P06280 1/20 0.51
PKM P14618 1/20 0.51
F10 P00742 3/20 0.50
MAPT P10636 3/20 0.50
KDM1A O60341 1/20 0.48
MAOB P27338 1/20 0.48
TSHR P16473 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
LMNA P02545 2/20 0.46
AURKA O14965 1/20 0.45
AURKB Q96GD4 1/20 0.45
HPGD P15428 2/20 0.45
CYP1A2 P05177 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5164810 0.92 F10 (0.60) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL5164898 0.88 SMN1; SMN2 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL7088328 0.85 MAPT (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1F10
SCHEMBL5163935 0.83 F10 (0.55) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL7091303 0.82 MAPT (0.66) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL6807106 0.81 F10 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL5164668 0.79 F10 (0.46) NPC1RAB9AF10TSHR
SCHEMBL6379444 0.78 F10 (0.57) NPC1RAB9ASMN1; SMN2ALDH1A1TP53
SCHEMBL7086320 0.77 ALDH1A1 (0.54) NPC1SMN1; SMN2ALDH1A1F10MAPT
SCHEMBL6750771 0.77 NPC1 (0.46) NPC1RAB9ASMN1; SMN2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US claimed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP claimed
CN-1518541-A Phenyl derivatives Ĭ��ר���ɷ����޹�˾ 2004-08-04 CN claimed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US claimed
EP-1341755-A1 CARBOXYLIC ACID AMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOEMBOLIC DISEASES AND TUMOURS MERCK PATENT GmbH (DE) 2003-09-10 EP claimed
WO-2002048099-A1 CARBOXYLIC ACID AMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF THROMBOEMBOLIC DISEASES AND TUMOURS MERCK PATENT GMBH (DE) 2002-06-20 WO claimed
US-7273867-B2 Phenyl derivatives MERCK PATENT GMBH (DE) 2007-09-25 US disclosed
EP-1351938-B1 PHENYL DERIVATIVES MERCK PATENT GMBH (DE) 2007-04-11 EP disclosed
CN-1518541-A Phenyl derivatives Ĭ��ר���ɷ����޹�˾ 2004-08-04 CN disclosed
US-20040087582-A1 Phenyl derivatives MERCK PATENT GESELLSCHAFT (DE) 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087582-A1 Phenyl derivatives F2, F11, SERPINC1 NPC1 1069/4885RAB9A 2014/4885SMN1; SMN2 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.